Stopbullying.gov releases Tumblr page to promote anti-bullying campaign; electronic cigarettes banned at Amity Regional High School in Woodbridge, Conn.; and the food and Drug Administration approves drug aimed at treating women in early stages of pregnancy. These stories and more top public health news on Tuesday, April 9, 2013.

Stopbullying.govReaching teens through social media
Bullying stops teens from being who they want to be, prevents them from expressing themselves freely, and might even make them feel unsafe. Bullying can happen anywhere, both in person and online. In this age of constant connectivity, and understanding the value teens place on their social networks, it’s only fitting to try and better reach them digitally. It’s no surprise that teens are highly visual, socially oriented, and always “connected.” They’re constantly on their phones and social networks sharing photos, providing encouragement to their friends, and communicating in a variety of ways. We saw this as an area where StopBullying.gov could grow and help reach teens where they are. We are excited to announce the launch of our new Tumblr page  for StopBullying.gov. This site will be used as a way to engage youth from across the country to take a stand against bullying in their schools. In bringing StopBullying.gov to Tumblr, we hope to start a conversation and encourage teens to be more than a bystander.

ABC LocalConnecticut high school bans electronic cigarettes
A high school in Connecticut wants to nix nicotine altogether, banning electronic cigarettes after some students were supposedly found using them in class. The Amity Regional High School, in Woodbridge, sent out a letter to parents saying that all smoking is prohibited, including e-cigarettes. The battery-powered devices allow the user to ingest nicotine through water vapors. The school district says right now, the e-cigarettes are perfectly legal for all ages, but there is legislation being developed to prevent anyone under 18 from using them. On top of that, though, the school district says the devices are unsafe. Some students agree with the policy, because of some of the things they are hearing. “I think they shouldn’t have it, because there are always ways to get drugs into them,” one student said. “I think if you ban it all completely, it would help out a lot.”

Los Angeles TimesFDA approves an old drug for morning sickness
The Food and Drug Administration on Monday approved a drug to treat the severe nausea and vomiting that some women experience during early pregnancy. The Canadian-made medication will be marketed as Diclegis. It is the only prescription medication approved for pregnant women experiencing “morning sickness” that does not go away with a bland diet of small meals that are low in fat. Diclegis was once known and marketed in the United States as Bendectin and taken by as many as one in 10 pregnant women. But after 27 years on the market, a spate of lawsuits in the early 1980s linked the drug to birth defects. Facing the prospect of steep legal damages, the firm manufacturing Bendectin, Merrell Dow Pharmaceuticals, pulled it from the U.S. market.

USA TodayStudy: Younger patients more likely to skip medications
People younger than 65 are twice as likely to skip medications than older Americans, according to a study released today by the federal Centers for Disease Control and Prevention. The new CDC study found that about 13% of the Americans younger than 65 did not take their medications as prescribed to save money, while 6% of the older group skipped medications. About 6% of both groups tried alternative therapies to avoid prescription drug costs. Researchers used data from the 2011 National Health Interview Survey, a survey that has gone out through the U.S. Census since 1956. Not taking medications as prescribed can lead to poorer health or emergency-room visits, according to the CDC report, a finding backed by other recent studies. In fact, the New England Healthcare Institute found that non-adherence to prescriptions costs Americans as much as $290 billion a year. And a University of Maryland study found last June that Medicare patients with chronic obstructive pulmonary disease who take their medications as prescribed had lower hospitalization rates and cost Medicare about $3,764 less than those who did not take their medications.